However, Hes1 promotes rapid tumorigenesis in a well-studied model of T-ALL in which expression of Id1 inhibits the function of E2A and HEB transcription factors [29], whose deficiency leads to T cell lymphoma [30]. The gene discussed is ID1; the disease is T-cell non-Hodgkin lymphoma.